Intuniv for ADHD: Uses, Side Effects, Dosage, and Sedation
Medically reviewed by Dr. Sireesha Kolli — Board-Certified Psychiatrist, Kolli Psychiatric & Associates, Red Bank, NJ
Last reviewed: June 2026
Intuniv is often considered when ADHD symptoms include impulsivity, emotional reactivity, or difficulty with self-regulation. This article explains where Intuniv may fit in ADHD treatment, what to expect during the first few weeks, and why sedation and tapering matter.
Quick Answer
Intuniv, also known as guanfacine extended-release, is a non-stimulant medication for ADHD that may be used alone or alongside a stimulant.
It works on a part of the brain called the prefrontal cortex to support attention, impulse control, and emotional regulation.
The starting dose is commonly 1 mg once daily, though dosing may be individualized by the prescriber. Some early benefits may appear within the first few weeks, but full clinical effect often becomes clearer over 4 to 6 weeks after the appropriate dose is achieved.
Drowsiness is the most common side effect. Intuniv is not a controlled substance and it should be tapered rather than stopped abruptly.
What is Intuniv?
Intuniv is the brand name for guanfacine extended-release. It is FDA-approved for ADHD in ages 6 to 17. It is designed to release gradually throughout the day.
Off-label, Intuniv may be used in adults with ADHD, in patients with ADHD plus tics or Tourette syndrome, in ADHD with autism spectrum features, and occasionally for selected anxiety- or hyperarousal-related symptoms when first-line treatments aren’t tolerated.
At Kolli Psychiatric & Associates, Intuniv is commonly used for ADHD patients with prominent emotional reactivity, patients who can’t tolerate or shouldn’t take stimulants, and as an addition to a stimulant when afternoon rebound becomes a problem.
A note on guanfacine formulations: Patients may also encounter Tenex, the immediate-release version of guanfacine. Tenex and Intuniv are not interchangeable. If Intuniv was prescribed, patients should confirm with the pharmacy that they are receiving the extended-release form.
Is Intuniv a stimulant?
Intuniv is not a stimulant.
Unlike stimulant medications such as Adderall or Vyvanse, Intuniv does not work by directly increasing dopamine. Because of that, it does not carry the same risk of misuse, dependence, or DEA scheduling.
It may be considered when stimulants are not appropriate, not tolerated, or raise concerns such as anxiety, misuse risk, or cardiovascular side effects.
What does Intuniv treat?
Intuniv treats ADHD in children and adolescents and may be used off-label in adults or in specific ADHD presentations.
ADHD in children and adolescents:
Intuniv is FDA-approved for ADHD in ages 6 to 17. It may help with inattention, hyperactivity, impulsivity, and emotional reactivity. It can be used alone or alongside stimulants.
ADHD in adults:
In adults, Intuniv is used off-label. It may be considered when stimulants are not tolerated, contraindicated, or insufficient on their own, especially when ADHD symptoms include anxiety, irritability, or rejection sensitivity.
ADHD with tics, Tourette syndrome, or autism spectrum features:
Intuniv may be considered when ADHD occurs alongside tics, Tourette syndrome, autism spectrum features, irritability, sensory reactivity, or emotional dysregulation.
Other off-label uses:
Less commonly, Intuniv may be considered for selected anxiety- or hyperarousal-related symptoms in patients who can’t tolerate first-line treatments.
Medication is one part of ADHD treatment; therapy, parent guidance, school supports, executive function coaching, or behavioral strategies may also be part of the plan.
Does Intuniv help with focus the way stimulants do?
Intuniv can support attention and executive function, but it usually does not produce the sharp, same-day cognitive boost that stimulants can.
This is an important expectation to set before starting Intuniv. Patients who expect a stimulant-like “on switch” may feel like it is not doing anything during the first few weeks. Intuniv works more gradually, strengthening the brain’s ability to regulate attention and behavior over time.
For patients whose main concern is demanding cognitive focus, stimulants are often more noticeable and faster to take effect. Intuniv tends to be considered when ADHD includes emotional dysregulation, low frustration tolerance, tics, autism spectrum features, stimulant side effects, anxiety, cardiovascular concerns, or substance use concerns.
A common clinical pattern is using Intuniv alongside a stimulant when a patient needs help with late-afternoon rebound, emotional volatility, or an edge that stimulant treatment alone does not fully address.
Considering Intuniv for ADHD?
› Understand whether Intuniv may fit your ADHD symptom pattern
› Get psychiatrist-guided support for dosing, side effects, and next steps
How does Intuniv work?
Intuniv works in the prefrontal cortex, the part of the brain involved in attention, decision-making, impulse control, and emotional regulation.
This area of the brain helps people pause, think, control reactions, and stay organized. In ADHD, these skills can be harder to access, especially when a person is stressed, frustrated, overstimulated, or emotionally overwhelmed.
Intuniv helps the prefrontal cortex work more steadily. Instead of giving a fast boost like a stimulant, it helps strengthen the brain’s ability to regulate attention and behavior over time. This is why patients may notice gradual changes, such as being less reactive, less impulsive, or better able to tolerate frustration.
This is why Intuniv usually feels subtler than a stimulant and may take several weeks to show its full benefit.
Because Intuniv and stimulants work differently, they are sometimes used together when a patient needs help with both focus and emotional regulation.
How does Intuniv make you feel?
Many patients describe Intuniv as subtle — not the fast-acting effect of a stimulant. The change is gradual: less reactive, calmer, more able to pause before acting, with no distinct on-off sensation.
Parents of children on Intuniv often report that meltdowns become less frequent, that homework time stops being a fight, and that the morning 0-to-60 reactivity starts to soften. Adult patients describe taking the static down — being less wound up, less prone to snapping, less flooded by small frustrations. The goal is not to change the patient’s personality; it is to reduce the volatility that gets in the way.
Sedation is the most noticeable physical effect, especially in the first 2 to 4 weeks. Patients often feel groggy in the morning or sleepy in the early afternoon during titration. This typically improves as the body adjusts. Slow titration and evening dosing during the early weeks can make Intuniv easier to tolerate.
Intuniv is generally not the right first choice for a patient whose main concern is sharp focus on demanding cognitive tasks — stimulants are usually more effective for that. Where Intuniv may be especially useful is on the regulation side: less reactive, less explosive, more able to sit with frustration. The question isn’t which ADHD medication is “best,” but which one fits the specific symptom pattern.
How should I take Intuniv?
Intuniv is taken once daily by mouth, starting at 1 mg and titrated up by 1 mg per week based on response and tolerability.
Standard dosing:
- Starting dose: 1 mg once daily
- Titration: increase by 1 mg every few weeks as clinically indicated
- Target dose for children ages 6–12: typically 1–4 mg daily
- Target dose for adolescents ages 13–17: typically 1–7 mg daily, weight-adjusted
- Maximum dose: 4 mg/day for ages 6–12; up to 7 mg/day for ages 13–17 in monotherapy
- When used with stimulants, dosing is typically limited to 4 mg/day
Higher doses are rarely used because sedation and blood pressure effects tend to outweigh additional benefit.
Food:
Do not take Intuniv with a high-fat meal. Doing so can significantly increase guanfacine levels and intensify sedation and blood pressure effects.
Tablet instructions:
Do not crush, chew, or split the tablet. Doing so can change how the medication is released and increase sedation and blood pressure effects.
Should I take Intuniv in the morning or at bedtime?
Intuniv can be taken in the morning or evening, but it should be taken at the same time each day. Because sedation is common during the first few weeks, many patients take it in the evening during titration to reduce daytime drowsiness. Once the body adjusts, timing can be reassessed based on side effects, sleep, and daytime functioning.
Missed dose:
If you remember the same day, take it. If it is close to the next scheduled dose, skip and resume the normal schedule the next day. Never double up. If two or more doses are missed in a row, contact your prescriber before restarting.
For adult patients using Intuniv off-label, dosing is individualized but typically follows the adolescent range, starting at 1 mg and titrating slowly based on response and side effects.
How long does Intuniv take to work?
Early changes typically appear within 2 to 4 weeks, with full therapeutic effect at 4 to 6 weeks.
This is the most common reason patients abandon Intuniv prematurely. Unlike stimulants, which produce a noticeable effect within an hour of the first dose, Intuniv works gradually as the brain adjusts to consistent alpha-2A receptor activation.
The first signs of improvement are usually subtle — slightly less reactivity, slightly easier transitions, slightly more patience — and patients often dismiss them as coincidence. Pediatric trials consistently show meaningful symptom reduction by weeks 4 to 6 at an optimized dose.
If there is no meaningful response after 6 to 8 weeks at an adequate dose, it’s reasonable to reconsider the medication or combination strategy. Our team — including Dr. Naqvi, who works extensively with children and adolescents — monitors patients closely during titration, with follow-up visits scheduled at the 4- and 8-week marks to assess response and adjust dosing.
ADHD Treatment Needs the Full Picture
› Medication choice depends on symptoms, side effects, and treatment goals
› A psychiatric evaluation can help clarify the safest next step
How long does Intuniv stay in your system?
Intuniv has a half-life of approximately 18 hours, with steady-state blood levels reached in about 4 to 5 days.
After stopping the medication, it generally clears the body within 4 to 5 days. Because Intuniv affects blood pressure and heart rate, the most important consideration after stopping isn’t how long it lingers but how the body responds to losing it — abrupt discontinuation can produce rebound elevations in blood pressure and heart rate. This is covered in the Stopping Intuniv section below.
Who should not take Intuniv?
Intuniv should be avoided or used cautiously in patients with low blood pressure, slow heart rate, a history of fainting, heart conduction problems, or serious heart disease, and in patients with known hypersensitivity to guanfacine.
- Low blood pressure or slow heart rate — Intuniv lowers both, so already-low values can drop further
- History of fainting — additional blood pressure drops can trigger episodes
- Heart conduction problems or serious heart disease — careful monitoring required if Intuniv is used
- Known hypersensitivity to guanfacine
- Caution with other antihypertensives — additive blood pressure effects may require dose adjustment
- Caution with strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir, grapefruit juice) — these roughly double guanfacine levels and require dose reduction
- Caution with strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John’s wort) — these reduce guanfacine effectiveness
Pregnancy considerations are addressed separately in the next section.
Is Intuniv safe during pregnancy?
There is limited human data on Intuniv during pregnancy; the medication is generally avoided unless other treatments have failed or are unacceptable.
Animal studies have shown some adverse effects at high doses, but human data are not robust enough to establish a clear risk profile. For most patients with ADHD, the decision is whether the symptoms are severe enough to justify continuing medication during pregnancy, since untreated ADHD can affect daily functioning, safety, and the ability to care for a pregnancy and a newborn.
It is not well established how much guanfacine passes into human breast milk, so breastfeeding decisions should be individualized with your psychiatrist and pediatrician.
If you’re planning pregnancy, currently pregnant, or breastfeeding, this is a conversation worth having early with both your psychiatrist and your obstetrician. The right choice depends on symptom severity, prior treatment response, alternatives considered, and your own priorities.
What are the side effects of Intuniv?
The most common side effects of Intuniv are drowsiness, fatigue, headache, dry mouth, and dizziness. These side effects are often most noticeable during the first 2 to 4 weeks of treatment and may improve as the body adjusts.
Because Intuniv can lower blood pressure and heart rate, some patients may feel dizzy, lightheaded, or faint, especially during titration or after dose increases. Dehydration, overheating, and standing up too quickly can make this more likely.
Common side effects (from the FDA prescribing information):
- Somnolence (drowsiness): approximately 30–40%
- Headache: approximately 24%
- Fatigue: approximately 14%
- Dry mouth: approximately 14%
- Dizziness: approximately 11%
- Abdominal pain: approximately 11%
- Decreased appetite: approximately 6–7%
- Nausea: approximately 6%
- Irritability: approximately 6%
Serious but rare side effects:
- Hypotension and bradycardia — meaningful drops in blood pressure or heart rate, especially during titration or with strong CYP3A4 inhibitors
- Syncope (fainting) — uncommon but reported, more likely with rapid titration
- AV block — rare cardiac conduction effect
- Mood changes — some patients report low mood, emotional flatness, or worsening depression at higher doses
- Rebound hypertension — if Intuniv is stopped abruptly rather than tapered
Intuniv does not carry an FDA black box warning. An ECG is not routinely required but is considered in patients with structural heart disease or family history of sudden cardiac death.
A note on weight: unlike stimulants, Intuniv is generally appetite-neutral or mildly appetite-increasing. Significant weight gain on Intuniv alone is uncommon, and for children whose appetite has been suppressed by stimulants, adding Intuniv sometimes coincides with appetite returning to normal.
Stopping Intuniv
Intuniv should be tapered gradually under provider supervision because abrupt discontinuation can cause rebound increases in blood pressure and heart rate.
This rebound is not addiction. Intuniv is not a controlled substance, and patients do not develop the cravings or compulsive use patterns that characterize addiction. What happens instead is straightforward physiology: the cardiovascular system has adapted to alpha-2A receptor activation, and removing it suddenly leaves blood pressure and heart rate temporarily higher than baseline. The effect is more pronounced at higher doses and with longer treatment.
The standard approach is to taper by 1 mg every 3 to 7 days, slower if rebound symptoms emerge. Patients on doses above 4 mg or who have been on Intuniv long-term often need a slower taper. Tapering should be done in coordination with the prescribing provider, particularly when transitioning to another ADHD medication, layering in therapy, or stopping ADHD treatment entirely.
If you started Intuniv elsewhere and need a stopping plan, the team at Kolli Psychiatric & Associates can guide a structured taper through telehealth across New Jersey, with cardiovascular monitoring built into the plan.
Key Takeaways
- Intuniv, also known as guanfacine extended-release, is a non-stimulant medication for ADHD.
- It is FDA-approved for ADHD in ages 6 to 17 and may be used off-label in adults.
- Intuniv works gradually and does not have the fast on/off feel of stimulant medications.
- It may be especially useful when ADHD includes emotional dysregulation, tics, autism spectrum features, or stimulant tolerability concerns.
- Drowsiness is the most common side effect and often improves within the first month.
- Intuniv tablets should not be crushed, chewed, or split.
- Intuniv is not a controlled substance, but it should be tapered rather than stopped abruptly because of rebound blood pressure and heart rate effects.
For more answers on dosing, side effects, and how Intuniv compares to other ADHD medications, see our Intuniv FAQ.
Looking for ADHD treatment in New Jersey?
Kolli Psychiatric & Associates provides comprehensive ADHD evaluation and treatment for children, adolescents, and adults across Monmouth County, Ocean County, and throughout New Jersey via telehealth.
Whether you are considering Intuniv, weighing it against stimulant medication, or exploring it as an addition to current ADHD treatment, our Red Bank-based team can help you think through the safest and most appropriate plan.
External Resources
